SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001504167-19-000007
Filing Date
2019-02-27
Accepted
2019-02-27 16:27:01
Documents
2
Period of Report
2019-02-27
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpmx-20190227x8k.htm 8-K 42806
2 EX-99.1 bpmx-20190227ex99150ec4b.htm EX-99.1 8623
  Complete submission text file 0001504167-19-000007.txt   52675
Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 19638110
SIC: 2834 Pharmaceutical Preparations